A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Clinical trial NCT06373146 · COMPLETED
Trial details
- NCT number
- NCT06373146
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-24
- Primary completion
- 2025-12-15
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.